Tislelizumab,Sorafenib
BeiGene,bayer
['tislelizumab', 'beigene', '$bgne']
$bgne - - beigene announces data presentations at esmo 2022 including late-breaking oral presentation for tislelizumab in first-line unresectable hepatocellular cancer
Building a platform where all investors are better informed and get smart about their investments. Please give a follow if you like what you see ??